A technician works at a manufacturing facility of Chinese vaccine maker CanSino Biologics in Tianjin, China. Photo: Reuters/China Out A technician works at a manufacturing facility of Chinese vaccine maker CanSino Biologics in Tianjin, China. Photo: Reuters/China Out
A technician works at a manufacturing facility of Chinese vaccine maker CanSino Biologics in Tianjin, China. Photo: Reuters/China Out

CanSino, China’s first drug maker to start human trials for Covid-19 vaccine, soars in Star Market trading debut

  • Pharmaceutical giant is first Chinese company to test a Covid-19 vaccine on humans
  • Will use funds to build manufacturing base, grow Covid-19 vaccine research

Topic |   China stock market
A technician works at a manufacturing facility of Chinese vaccine maker CanSino Biologics in Tianjin, China. Photo: Reuters/China Out A technician works at a manufacturing facility of Chinese vaccine maker CanSino Biologics in Tianjin, China. Photo: Reuters/China Out
A technician works at a manufacturing facility of Chinese vaccine maker CanSino Biologics in Tianjin, China. Photo: Reuters/China Out
READ FULL ARTICLE